| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SYRE | Spyre Therapeutics, Inc. | Burrows Scott L | Chief Financial Officer | Sep 03, 2024 | Sale | $28.17 | 18,531 | 522,074 | 116,422 | Sep 05, 2024, 04:04 PM | |
| ARQT | Arcutis Biotherapeutics, Inc. | Burrows Scott L | Chief Financial Officer | Mar 06, 2023 | Sale | $15.26 | 291 | 4,442 | 59,115 | Mar 08, 2023, 04:29 PM | |
| ARQT | Arcutis Biotherapeutics, Inc. | Burrows Scott L | Chief Financial Officer | Feb 28, 2023 | Sale | $16.17 | 416 | 6,725 | 39,840 | Mar 02, 2023, 07:05 PM | |
| ARQT | Arcutis Biotherapeutics, Inc. | Burrows Scott L | Chief Financial Officer | Mar 02, 2023 | Sale | $15.83 | 1,434 | 22,696 | 38,424 | Mar 02, 2023, 07:05 PM | |
| ARQT | Arcutis Biotherapeutics, Inc. | Burrows Scott L | Chief Financial Officer | Sep 16, 2022 | Option Exercise | $1.68 | 5,000 | 8,403 | 40,256 | Sep 20, 2022, 04:37 PM | |
| ARQT | Arcutis Biotherapeutics, Inc. | Burrows Scott L | Chief Financial Officer | Mar 04, 2022 | Sale | $16.86 | 293 | 4,940 | 35,266 | Mar 07, 2022, 08:49 PM | |
| ARQT | Arcutis Biotherapeutics, Inc. | Burrows Scott L | Chief Financial Officer | Mar 07, 2022 | Sale | $16.44 | 10 | 164 | 35,256 | Mar 07, 2022, 08:49 PM | |
| ARQT | Arcutis Biotherapeutics, Inc. | Burrows Scott L | Chief Financial Officer | Dec 27, 2021 | Sale | $20.07 | 12,560 | 252,139 | 22,679 | Dec 28, 2021, 05:00 PM |
Menu